STX
52
2
CMG
57
-6
LUV
39
-5
PRGO
39
-4
EQR
44
7
TRV
46
-3
EXPE
74
2
NI
60
2
MU
35
3
FOXA
59
7
WU
22
4
PBI
60
17
MAT
62
2
ORLY
57
3
FOX
51
9
HSIC
45
8
UA
39
3
L
47
-5
STI
19
-21
COF
57
-2
STX
52
2
CMG
57
-6
LUV
39
-5
PRGO
39
-4
EQR
44
7
TRV
46
-3
EXPE
74
2
NI
60
2
MU
35
3
FOXA
59
7
WU
22
4
PBI
60
17
MAT
62
2
ORLY
57
3
FOX
51
9
HSIC
45
8
UA
39
3
L
47
-5
STI
19
-21
COF
57
-2
Financhill
Back

Halozyme Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
72

HALO
Halozyme Therapeutics

Last Price:
57.96
Seasonality Move:
16.49%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Halozyme Therapeutics Price Quote

$57.96
-0.50 (-0.86%)
(Updated: November 5, 2024 at 2:35 PM ET)

Halozyme Therapeutics Key Stats

Buy
72
Halozyme Therapeutics (HALO) is a Buy
Day range:
$56.82 - $59.39
52-week range:
$33.15 - $65.53
Dividend yield:
0%
P/E ratio:
27.84
P/S ratio:
8.01
P/B ratio:
16.43%
Volume:
1.9M
Avg. volume:
1.4M
1-year change:
64.31%
Market cap:
$7.4B
Revenue:
$829.3M
EPS:
$3.02

How Much Does Halozyme Therapeutics Make?

Is Halozyme Therapeutics Growing As A Company?

  • What Is Halozyme Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Halozyme Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.72%

Halozyme Therapeutics Stock Price Performance

What Is Halozyme Therapeutics 52-Week High & Low?

Halozyme Therapeutics Price To Free Cash Flow

Is It Risky To Buy Halozyme Therapeutics?

Is Halozyme Therapeutics Cash Flow Positive?

  • What Is HALO Cash Flow From Operations?
    Cash flow from operations (TTM) is $403M
  • What Is Halozyme Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$222.4M
  • What Is Halozyme Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$300.5M

Halozyme Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    HALO return on invested capital is 22.41%
  • What Is Halozyme Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 20.54%
  • What Is HALO Return On Equity?
    ROE is a measure of profitability and is 156.62%

Halozyme Therapeutics Earnings Date & Stock Price

Halozyme Therapeutics Competitors

Halozyme Therapeutics Dividend Yield

Halozyme Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 72.13% 27.05%
Revenue: 34.28% 15.04%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 62.60
Upside from Last Price: 7.08%

Major Shareholders

  • How many HALO shares are owned by institutional investors?
    204.5M HALO shares are owned by institutional investors
  • How many HALO shares are owned by insiders?
    11.5M HALO shares are owned by insiders